A year later, shortages of infant formula continue to plague families across the country, and no help from the Biden administration appears to be in sight.
– Advertisement –
INFANT FORMULA STILL IS DIFFICULT TO FIND AFTER ALMOST A YEAR OF DEFICIENCY
FOX Business Lydia Hu spoke to pharmacy owner Anil Datwani, who warned parents that demand for infant formula is rising while supply is shrinking.
– Advertisement –
“It’s getting harder and harder,” the AR-Ex pharmacy owner said, adding that Enfamil AR, Enfamil Gentlease NeuroPro is “difficult to find.”
“[Mothers] move from one store to another store, to the next store,” he explained, looking for these formulas.
The infant formula shortage began in February 2022, but despite the Biden administration’s assurances that they are working “around the clock” to fix the problem, shortages continue to burden American mothers in March 2023.
DEFICIENCY OF INFANT FORMULA CONTINUES UP TO EIGHT MONTHS
In an effort to take constructive action, Republicans in the House of Representatives launched an investigation into the “bad response” of the Food and Drug Administration (FDA) to infant formula shortages in mid-2021 on Tuesday.
The House Oversight Committee wants to speak with former FDA official Frank Yannas, who oversaw the infant formula crisis during its initial eruption last year. Yannas shocked many when he resigned from the FDA earlier this year.
House Oversight Committee Chairman James Comer, of Kentucky, sent a letter to FDA Commissioner Robert Kaliff requesting all administration communications regarding the shortage and its response. Kaliff announced in January that the FDA will not fire anyone because of his reaction to the crisis.
FDA PROPOSES LIMITING LEAD IN CHILDREN’S FOOD
Comer’s letter refers to a third-party review of the FDA’s response that found the organization lacked urgency and motivation to respond to the shortage.
LACK OF INFANT FORMULA: FDA REPORT ANSWERS OLD SYSTEM, PREPARATION PROBLEMS
“Despite this report and the acknowledged need for a major overhaul, you have stated that there will be no reassignments or layoffs due to the administration’s response to infant formula shortages,” Comer wrote in a letter. “We are requesting documents and communications to understand the FDA’s response to the lack of infant formula.”
Ministry of Justice is conducting a criminal investigation into the manufacturer of the popular Similac blend brand, Abbott Laboratories, with the FTC and SEC launching their own investigation into the matter.
Numerous lawsuits continue to be filed against Abbott Laboratories.
Fox News Anders Hagstrom contributed to this report.